FDA Adverse Event Malfunction Summary report: N

ARCHITECT C8000

MDR report key: 16673129 · Received April 4, 2023

Report

Report Number
3016438761-2023-00176
Event Type
Malfunction
Date Received
April 4, 2023
Date of Event
March 12, 2023
Report Date
April 18, 2023
Manufacturer
ABBOTT LABORATORIES
Product Code
JJE
UDI-DI
00380740000509
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.

Additional Manufacturer Narrative · 0

THE FIELD SERVICE REPRESENTATIVE (FSR) INSPECTED THE INSTRUMENT, PERFORMED TROUBLESHOOTING PROCEDURES INCLUDING REBUILDING THE SAMPLE SYRINGE, REPLACING THE SAMPLE PROBE TUBING AND THE TBG, SMPL PMP TO PIPET JNT, NS (ROHS) AS IT WAS KINKED AND CAUGHT UNDER A PANEL. PART REPLACEMENT RESOLVED THE ISSUE. NO ADDITIONAL DISCREPANT RESULT TOTAL BILIRUBIN ISSUES HAVE BEEN REPORTED SINCE THE SERVICE ACTIVITY WAS COMPLETED. THE TBG, SMPL PMP TO PIPET JNT, NS (ROHS) WAS DETERMINED TO BE THE CAUSE OF THE ISSUE. THE ARCHITECT C8000 ERRATIC RESULT RATES WERE WITHIN ACCEPTABLE LIMITS WITH NO TRENDS IDENTIFIED. TRENDING REVIEW DID NOT IDENTIFY ANY TRENDS FOR THE ISSUE UNDER REVIEW. LABELING REVIEW CONCLUDES THAT THE ISSUE IS ADEQUATELY ADDRESSED. BASED ON THE INVESTIGATION, NO DEFICIENCY WAS IDENTIFIED.

Description of Event or Problem · 0

THE CUSTOMER OBSERVED FALSELY DEPRESSED TOTAL BILIRUBIN RESULTS GENERATED ON THE ARCHITECT C8000 PROCESSING MODULE FOR ONE PATIENT. THE FOLLOWING DATA WAS PROVIDED (REFERENCE RANGE 0.2 TO 1.3 MG/DL): SID L913045389 INITIAL 0.6 MG/DL, REPEAT 9.9 MG/DL. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
385910 ARCHITECT C8000 ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE JJE ABBOTT LABORATORIES 1G06-11 00380740000509

Patients

Seq Age Sex Outcome Treatment
1 Unknown CC TOTAL BILI (3840T), 06L45-42, 62899UQ09| CC TOTAL BILI (3840T), 06L45-42, 62899UQ09